SARS-CoV-2-induced myocarditis: a state-of-the-art review

F Nappi, SS Avtaar Singh - Viruses, 2023 - mdpi.com
In this review, we investigated whether severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) can directly cause myocarditis with severe myocardial damage induced by …

[HTML][HTML] Dementia as risk factor for severe coronavirus disease 2019: a case-control study

M Pisaturo, F Calò, A Russo, C Camaioni… - Frontiers in Aging …, 2021 - frontiersin.org
Background The aim of the present study was to investigate the outcome of patients with
SARS-CoV-2 infection and dementia. Patients and Methods In a multicenter, observational …

The potential role of cytokine storm pathway in the clinical course of viral respiratory pandemic

G Murdaca, F Paladin, A Tonacci, S Isola, A Allegra… - Biomedicines, 2021 - mdpi.com
The “cytokine storm”(CS) consists of a spectrum of different immune dysregulation disorders
characterized by constitutional symptoms, systemic inflammation and multiorgan dysfunction …

Pharmacogenomics of genetic polymorphism within the genes responsible for SARS‐CoV‐2 susceptibility and the drug‐metabolising genes used in treatment

LN AL‐Eitan, SZ Alahmad - Reviews in medical virology, 2021 - Wiley Online Library
The ongoing outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
represents a significant challenge to international health. Pharmacogenomics aims to …

microRNAs and inflammatory immune response in SARS-CoV-2 infection: a narrative review

B Maranini, G Ciancio, M Ferracin, R Cultrera… - Life, 2022 - mdpi.com
The current SARS-CoV-2 pandemic has emerged as an international challenge with strong
medical and socioeconomic impact. The spectrum of clinical manifestations of SARS-CoV-2 …

[HTML][HTML] Chemokine regulation during epidemic coronavirus infection

S Majumdar, PM Murphy - Frontiers in Pharmacology, 2021 - frontiersin.org
SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus-2) is the third coronavirus to
emerge as a cause of severe and frequently fatal pneumonia epidemics in humans, joining …

The SARS-coV-2/receptor axis in heart and blood vessels: A crisp update on COVID-19 disease with cardiovascular complications

P Veluswamy, M Wacker, D Stavridis, T Reichel… - Viruses, 2021 - mdpi.com
The SARS-CoV-2 virus causing COVID-19 disease has emerged expeditiously in the world
and has been declared pandemic since March 2020, by World Health Organization (WHO) …

[PDF][PDF] Meta-analysis of the impact of physical activity on the recovery of physical function in COVID-19 patients

G Yang, Z Li, Z Li, L Huang, P Liang, L Liu, D Li - Heliyon, 2023 - cell.com
Background The decrease in physical function resulting from COVID-19 infection exerts a
substantial negative influence on the quality of life of individuals. Physical activity plays a …

Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab

L Salvati, M Occhipinti, L Gori, L Ciani, A Mazzoni… - Immunology …, 2020 - Elsevier
As of October 2020 management of Coronavirus disease 2019 (COVID-19) is based on
supportive care and off-label or compassionate-use therapies. On March 2020 tocilizumab …

Immunity Agent-Based Model (IABM) for epidemiological systems

MN Gonzaga, MM de Oliveira, APF Atman - Chaos, Solitons & Fractals, 2023 - Elsevier
COVID-19 was one of the pandemic episodes that has afflicted humanity in the last centuries
and may not be the last. In science, the intense spread of the SARS-CoV-2 virus boosted the …